{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:40:28Z","timestamp":1767066028504,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP2024R261"],"award-info":[{"award-number":["RSP2024R261"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11030-024-11079-1","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T07:10:53Z","timestamp":1736406653000},"page":"3233-3252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating machine learning and structural dynamics to explore B-cell lymphoma-2 inhibitors for chronic lymphocytic leukemia therapy"],"prefix":"10.1007","volume":"29","author":[{"given":"Rima","family":"Bharadwaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer M.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek Dhar","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarad Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"11079_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/cancers12020282","volume":"12","author":"C Vitale","year":"2020","unstructured":"Vitale C, Montalbano MC, Salvetti C et al (2020) Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs. Cancers 12:282. https:\/\/doi.org\/10.3390\/cancers12020282","journal-title":"Cancers"},{"key":"11079_CR2","unstructured":"Mukkamalla SKR, Taneja A, Malipeddi D, Master SR (2024) Chronic lymphocytic leukemia. In: StatPearls. StatPearls Publishing, Treasure Island"},{"key":"11079_CR3","unstructured":"S R, Jm N, P G et al (2006) Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. PubMed"},{"key":"11079_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-pathol-020712-163955","volume":"9","author":"S Zhang","year":"2014","unstructured":"Zhang S, Kipps TJ (2014) The pathogenesis of chronic lymphocytic leukemia. Annu Rev Pathol 9:103\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-020712-163955","journal-title":"Annu Rev Pathol"},{"key":"11079_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","volume":"34","author":"JA Burger","year":"2013","unstructured":"Burger JA, Chiorazzi N (2013) B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol 34:592\u2013601. https:\/\/doi.org\/10.1016\/j.it.2013.07.002","journal-title":"Trends Immunol"},{"key":"11079_CR6","unstructured":"The BCL-2 arbiters of apoptosis and their growing role as cancer targets | Cell Death & Differentiation. https:\/\/www.nature.com\/articles\/cdd2017161. Accessed 27 Jul 2024"},{"key":"11079_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/cdd.2017.30","volume":"24","author":"EM Carrington","year":"2017","unstructured":"Carrington EM, Zhan Y, Brady JL et al (2017) Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death Differ 24:878\u2013888. https:\/\/doi.org\/10.1038\/cdd.2017.30","journal-title":"Cell Death Differ"},{"key":"11079_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W et al (2022) The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol 12:985363. https:\/\/doi.org\/10.3389\/fonc.2022.985363","journal-title":"Front Oncol"},{"key":"11079_CR9","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.3390\/cancers14215337","volume":"14","author":"L Zawil","year":"2022","unstructured":"Zawil L, Marchiol T, Brauge B et al (2022) Distinct B-cell specific transcriptional contexts of the BCL2 oncogene impact pre-malignant development in mouse models. Cancers 14:5337. https:\/\/doi.org\/10.3390\/cancers14215337","journal-title":"Cancers"},{"key":"11079_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/cancers12040938","volume":"12","author":"M Klanova","year":"2020","unstructured":"Klanova M, Klener P (2020) BCL-2 proteins in pathogenesis and therapy of B-cell non-hodgkin lymphomas. Cancers 12:938. https:\/\/doi.org\/10.3390\/cancers12040938","journal-title":"Cancers"},{"key":"11079_CR11","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.3390\/cancers15204957","volume":"15","author":"J Xu","year":"2023","unstructured":"Xu J, Dong X, Huang DCS et al (2023) Current advances and future strategies for BCL-2 inhibitors: potent weapons against cancers. Cancers 15:4957. https:\/\/doi.org\/10.3390\/cancers15204957","journal-title":"Cancers"},{"key":"11079_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/jpm11060463","volume":"11","author":"M Lasica","year":"2021","unstructured":"Lasica M, Anderson MA (2021) Review of venetoclax in CLL, AML and multiple myeloma. J Pers Med 11:463. https:\/\/doi.org\/10.3390\/jpm11060463","journal-title":"J Pers Med"},{"key":"11079_CR13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/cancers16061091","volume":"16","author":"S Garciaz","year":"2024","unstructured":"Garciaz S, Hospital M-A, Collette Y, Vey N (2024) Venetoclax resistance in acute myeloid leukemia. Cancers 16:1091. https:\/\/doi.org\/10.3390\/cancers16061091","journal-title":"Cancers"},{"key":"11079_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66:334\u2013395. https:\/\/doi.org\/10.1124\/pr.112.007336","journal-title":"Pharmacol Rev"},{"key":"11079_CR15","unstructured":"Aggarwal G Computational Drug Design: Unleashing the Power of Virtual Molecules | International Journal of Drug Research and Technology"},{"key":"11079_CR16","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2023","unstructured":"Zdrazil B, Felix E, Hunter F et al (2023) The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res 52:D1180\u2013D1192. https:\/\/doi.org\/10.1093\/nar\/gkad1004","journal-title":"Nucleic Acids Res"},{"key":"11079_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41467-022-35692-6","volume":"14","author":"M Moret","year":"2023","unstructured":"Moret M, Pachon Angona I, Cotos L et al (2023) Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nat Commun 14:114","journal-title":"Nat Commun"},{"key":"11079_CR18","unstructured":"Lipinski\u2019s Rule of Five - an overview | ScienceDirect Topics. https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/lipinskis-rule-of-five. Accessed 2 Jan 2024"},{"key":"11079_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242","journal-title":"Nucleic Acids Res"},{"key":"11079_CR20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"11079_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"11079_CR22","doi-asserted-by":"publisher","first-page":"W448","DOI":"10.1093\/nar\/gkv306","volume":"43","author":"CM Labb\u00e9","year":"2015","unstructured":"Labb\u00e9 CM, Rey J, Lagorce D et al (2015) MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43:W448\u2013W454","journal-title":"Nucleic Acids Res"},{"key":"11079_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA, Cheatham TE, Darden T et al (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668\u20131688. https:\/\/doi.org\/10.1002\/jcc.20290","journal-title":"J Comput Chem"},{"key":"11079_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW et al (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"11079_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247\u2013260. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005","journal-title":"J Mol Graph Model"},{"key":"11079_CR26","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105:9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w","journal-title":"J Phys Chem A"},{"key":"11079_CR27","unstructured":"A compression strategy for particle mesh Ewald theory\u2014PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7986272\/. Accessed 5 Jun 2024"},{"key":"11079_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1140\/epjst\/e2011-01525-9","volume":"200","author":"R Elber","year":"2011","unstructured":"Elber R, Ruymgaart AP, Hess B (2011) SHAKE parallelization. Eur Phys J Spec Top 200:211\u2013223. https:\/\/doi.org\/10.1140\/epjst\/e2011-01525-9","journal-title":"Eur Phys J Spec Top"},{"key":"11079_CR29","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM et al (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","journal-title":"J Chem Theory Comput"},{"key":"11079_CR30","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.compbiolchem.2020.107322","volume":"87","author":"LP Kagami","year":"2020","unstructured":"Kagami LP, Das Neves GM, Timmers LFSM et al (2020) Geo-measures: a PyMOL plugin for protein structure ensembles analysis. Comput Biol Chem 87:107322. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107322","journal-title":"Comput Biol Chem"},{"key":"11079_CR31","doi-asserted-by":"publisher","first-page":"7836","DOI":"10.1021\/acs.jmedchem.4c00027","volume":"67","author":"Y Guo","year":"2024","unstructured":"Guo Y, Xue H, Hu N et al (2024) Discovery of the clinical candidate sonrotoclax (BGB-11417), a highly potent and selective inhibitor for both WT and G101V Mutant Bcl-2. J Med Chem 67:7836\u20137858. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00027","journal-title":"J Med Chem"},{"key":"11079_CR32","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: An open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82\u201392","journal-title":"CCP4 Newsl Protein Crystallogr"},{"key":"11079_CR33","unstructured":"Studio D (2008) Discovery studio. Accelrys 21"},{"key":"11079_CR34","doi-asserted-by":"publisher","first-page":"34984","DOI":"10.1038\/srep34984","volume":"6","author":"I Aier","year":"2016","unstructured":"Aier I, Varadwaj PK, Raj U (2016) Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Sci Rep 6:34984. https:\/\/doi.org\/10.1038\/srep34984","journal-title":"Sci Rep"},{"key":"11079_CR35","doi-asserted-by":"publisher","DOI":"10.1039\/D3CP03492E","author":"N Wu","year":"2024","unstructured":"Wu N, Zhang R, Peng X et al (2024) Elucidation of protein\u2013ligand interactions by multiple trajectory analysis methods. Phys Chem Chem Phys. https:\/\/doi.org\/10.1039\/D3CP03492E","journal-title":"Phys Chem Chem Phys"},{"key":"11079_CR36","doi-asserted-by":"publisher","first-page":"128933","DOI":"10.1016\/j.foodchem.2020.128933","volume":"346","author":"J Sharma","year":"2021","unstructured":"Sharma J, Kumar Bhardwaj V, Singh R et al (2021) An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2. Food Chem 346:128933. https:\/\/doi.org\/10.1016\/j.foodchem.2020.128933","journal-title":"Food Chem"},{"key":"11079_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva N, Galzitskaya O (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628","journal-title":"Mol Biol"},{"key":"11079_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.12691\/ajmo-5-1-3","volume":"5","author":"MJR Yunta","year":"2017","unstructured":"Yunta MJR (2017) It is important to compute intramolecular hydrogen bonding in drug design? Am J Model Optim 5:24\u201357. https:\/\/doi.org\/10.12691\/ajmo-5-1-3","journal-title":"Am J Model Optim"},{"key":"11079_CR39","doi-asserted-by":"publisher","first-page":"e1501240","DOI":"10.1126\/sciadv.1501240","volume":"2","author":"D Chen","year":"2016","unstructured":"Chen D, Oezguen N, Urvil P et al (2016) Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci Adv 2:e1501240. https:\/\/doi.org\/10.1126\/sciadv.1501240","journal-title":"Sci Adv"},{"key":"11079_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/acs.jpcb.6b11696","volume":"121","author":"K Moritsugu","year":"2017","unstructured":"Moritsugu K, Terada T, Kidera A (2017) Free-energy landscape of protein-ligand interactions coupled with protein structural changes. J Phys Chem B 121:731\u2013740. https:\/\/doi.org\/10.1021\/acs.jpcb.6b11696","journal-title":"J Phys Chem B"},{"key":"11079_CR41","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton A, Hersey A, Nowotka M et al (2017) The ChEMBL database in 2017. Nucleic Acids Res 45:D945\u2013D954","journal-title":"Nucleic Acids Res"},{"key":"11079_CR42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","volume":"9","author":"T Nechiporuk","year":"2019","unstructured":"Nechiporuk T, Kurtz SE, Nikolova O et al (2019) The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discov 9:910\u2013925. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0125","journal-title":"Cancer Discov"},{"key":"11079_CR43","unstructured":"Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer\u2014ScienceDirect. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S030438352400017X. Accessed 27 Jul 2024"},{"key":"11079_CR44","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/ct9005745","volume":"6","author":"GG Maisuradze","year":"2010","unstructured":"Maisuradze GG, Liwo A, Scheraga HA (2010) Relation between free energy landscapes of proteins and dynamics. J Chem Theory Comput 6:583\u2013595. https:\/\/doi.org\/10.1021\/ct9005745","journal-title":"J Chem Theory Comput"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11079-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:05:13Z","timestamp":1757127913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11079-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["11079"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11079-1","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}